Skip to main navigation Skip to search Skip to main content

Phase 1 study of the MDM2 inhibitor AMG 232 in patients with advanced P53 wild-type solid tumors or multiple myeloma

  • WL Gluck
  • , MM Gounder
  • , R Frank
  • , Ferry Eskens
  • , JY Blay
  • , PA Cassier
  • , JC Soria
  • , S Chawla
  • , V de Weger
  • , AJ Wagner
  • , D Siegel
  • , F Vos
  • , E Rasmussen
  • , HA Henary

Research output: Contribution to journalArticleAcademicpeer-review

117 Citations (Scopus)
42 Downloads (Pure)
Original languageEnglish
Pages (from-to)831-843
Number of pages13
JournalInvestigational New Drugs
Volume38
Issue number3
DOIs
Publication statusPublished - 2020

Research programs

  • EMC OR-01

Cite this